Immunotherapy in Combination With Ablative Radiosurgery to Ultra-high DoSes (ICARUS): A Phase I Dose-escalation Radiosurgery Study in Metastatic Cancers
Latest Information Update: 07 Jul 2025
At a glance
- Drugs Atezolizumab (Primary)
- Indications Cancer; Colorectal cancer; Head and neck cancer; Lung cancer; Ovarian cancer; Sarcoma
- Focus Adverse reactions
Most Recent Events
- 29 Jun 2025 Status changed from not yet recruiting to withdrawn prior to enrolment because of an impasse during contract negotiations.
- 20 May 2024 New trial record